The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9073941, 1007 ID: ALA3970460
Chembl Id: CHEMBL3970460
PubChem CID: 2333406
Max Phase: Preclinical
Molecular Formula: C21H18BrN5O2
Molecular Weight: 452.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCn1c(NC(=O)c2ccc(Br)o2)c(C#N)c2nc3ccccc3nc21
Standard InChI: InChI=1S/C21H18BrN5O2/c1-2-3-6-11-27-19(26-21(28)16-9-10-17(22)29-16)13(12-23)18-20(27)25-15-8-5-4-7-14(15)24-18/h4-5,7-10H,2-3,6,11H2,1H3,(H,26,28)
Standard InChI Key: ULXACOANXABOHE-UHFFFAOYSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 452.31Molecular Weight (Monoisotopic): 451.0644AlogP: 5.25#Rotatable Bonds: 6Polar Surface Area: 96.74Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.12CX Basic pKa: ┄CX LogP: 4.71CX LogD: 4.71Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.40Np Likeness Score: -1.80
References 1. (2015) Compounds and methods for treating tuberculosis infection,